Text Size

Intravitreal Sirolimus for Noninfectious Uveitis: A Phase III Sirolimus Study Assessing Double-masKed Uveitis TReAtment (SAKURA)

Nguyen Q.D., Merrill P.T., Clark W.L., Banker A.S., Fardeau C., Franco P., LeHoang P., Ohno S., Rathinam S.R., Thurau S., Abraham A., Wilson L., Yang Y., Shams N., Sirolimus study Assessing double-masKed Uveitis tReAtment (SAKURA) Study Group


  • 2016
  • Ophthalmology
View publication
  • Therapeutic Area

    Back of the eye (BOTE)

  • Categories

    Clinical development

  • Affiliations

    Ocular Imaging Research and Reading Center (OIRRC), Omaha, Nebraska, United States; Department of Ophthalmology, Rush University Medical Center, Chicago, Illinois, United States; Palmetto Retina Center, LLC, West Columbia, South Carolina, United States; Banker's Retina Clinic and Laser Center, Navrangpura, Ahmedabad, India; Department of Ophthalmology, Pitie-Salpetriere Hospital, University Pierre et Marie Curie, Paris VI, Paris, France; Organización Médica de Investigación, Uruguay 725 PB, Buenos Aires, Argentina; Department of Ophthalmology, Hokkaido University Graduate School of Medicine, Sapporo, Hokkaido, Japan; Aravind Eye Hospital, Madurai, Tamil Nadu, India; Department of Ophthalmology, Ludwig-Maximillians-University, Munich, Germany; Santen, Inc., Emeryville, California, United States; Genentech, Inc., South San Francisco, California, United States

Related Publications

Prospective natural history and clinical biomarkers of EYS-associated retinopathy in the KEYS study

Taniguchi M, Togashi Y, Yokota S, Hiraoka M, Kitahata S, Nakamura N, Yamamoto M, Mandai M, Gocho K, Toshimori M, Hirami Y, Gomi F, Kurimoto Y, Maeda A.


STudy of Atropine to Reduce (STAR) Myopia Progression in Children: 24‑Month Results of a Randomized, Double‑Masked, Vehicle‑Controlled Trial of Atropine Sulfate 0.01% and 0.03%

Korenfeld M.; Hurcikova M.; Tatsuoka K.; Cheetham J.; Kacerik M.; on behalf of the STAR Study Investigators


Consensus on evidence gaps and unmet needs in childhood myopia: findings from a European Delphi study with eye care professionals and payers

Lagreze W, Nucci P, Versteegh M, Klaver C, Barrio-Barrio J, Dahlmann-Noor A, Gomez de Liaño R, Ghorbani-Mojarrad N, Kessel L, Polling JR, Sauer A, Schuster AK, Serafino M, Villani E, Ziemssen F, Boehler YB, Capri S, Gianfrate F, Valles Callol JA, Wong O, Chen TY, Lymperopoulou C, Palaka I, Punekar Y, von Bredow D, Shi-van Wielink K.


Can't find what you're looking for?

Contact us

Document number: NP-No product-EMEA-0110
Date of preparation: February 2022